Human Pheromone Sciences Inc logo

EROX - Human Pheromone Sciences Inc Share Price

$0.02 0.0  0.0%

Last Trade - 29/06/20

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £65.8k
Enterprise Value £11.1k
Revenue £513k
Position in Universe th / 6337
Bullish
Bearish
Unlock EROX Revenue
Momentum
Relative Strength (%)
1m +27.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2005 2006 2007 2008 2009 2010 2011E 2012E CAGR / Avg
0.41 1.23 1.29 0.99 0.89 0.81 +14.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2011, Human Pheromone Sciences, Inc. revenues decreased 27% to $423K. Net loss decreased 74% to $56K. Revenues reflect Licensce Revenue (Worldwide) segment decrease of 35% to $85K, U.S. Market segment decrease of 56% to $28K. Lower net loss reflects Selling, general and administrative decrease of 40% to $385K (expense), Research and development decrease of 65% to $14K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EROX Revenue Unlock EROX Revenue

Net Income

EROX Net Income Unlock EROX Revenue

Normalised EPS

EROX Normalised EPS Unlock EROX Revenue

PE Ratio Range

EROX PE Ratio Range Unlock EROX Revenue

Dividend Yield Range

EROX Dividend Yield Range Unlock EROX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EROX EPS Forecasts Unlock EROX Revenue
Profile Summary

Human Pheromone Sciences, Inc. is a science based company. The Company produces all Natural Attraction products. The Company engages in the research, development, manufacturing and marketing of human pheromones and consumer products containing human pheromones as a component. The Company focuses on the development of human-pheromone based products under its Natural Attraction brand and licenses other companies to use the Company's patented technology in their proprietary brands and products. The Company distributes these products via www.naturalattraction.com. The Company has developed a line of fragrance products for men and women under the, Natural Attraction name. The Company’s research and development laboratories are in Salt Lake City, Utah.

Directors
Last Annual December 31st, 2010
Last Interim September 30th, 2011
Incorporated November 28, 1989
Public Since February 8, 2000
No. of Shareholders: 530
No. of Employees: 2
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange OTC Markets Group
Shares in Issue 4,151,954
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EROX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EROX
Upcoming Events for EROX
Frequently Asked Questions for Human Pheromone Sciences Inc
What is the Human Pheromone Sciences Inc share price?

As of 29/06/20, shares in Human Pheromone Sciences Inc are trading at $0.02, giving the company a market capitalisation of £65.8k. This share price information is delayed by 15 minutes.

How has the Human Pheromone Sciences Inc share price performed this year?

Shares in Human Pheromone Sciences Inc are currently trading at $0.02 and the price has moved by 98.02% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Human Pheromone Sciences Inc price has moved by 96.82% over the past year.

What are the analyst and broker recommendations for Human Pheromone Sciences Inc?

There are no analysts currently covering Human Pheromone Sciences Inc.

When will Human Pheromone Sciences Inc next release its financial results?

Human Pheromone Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2012-09-30
What is the Human Pheromone Sciences Inc dividend yield?

Human Pheromone Sciences Inc does not currently pay a dividend.

Does Human Pheromone Sciences Inc pay a dividend?

Human Pheromone Sciences Inc does not currently pay a dividend.

When does Human Pheromone Sciences Inc next pay dividends?

Human Pheromone Sciences Inc does not currently pay a dividend.

How do I buy Human Pheromone Sciences Inc shares?

To buy shares in Human Pheromone Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Human Pheromone Sciences Inc?

Shares in Human Pheromone Sciences Inc are currently trading at $0.02, giving the company a market capitalisation of £65.8k.

Where are Human Pheromone Sciences Inc shares listed? Where are Human Pheromone Sciences Inc shares listed?

Here are the trading details for Human Pheromone Sciences Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: EROX
What kind of share is Human Pheromone Sciences Inc?

We were not able to load our ranking data for Human Pheromone Sciences Inc

Is there a Human Pheromone Sciences Inc share price forecast 2020?

We were not able to load any forecast data for Human Pheromone Sciences Inc.

How can I tell whether the Human Pheromone Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Human Pheromone Sciences Inc. Over the past six months, the relative strength of its shares against the market has been 0.290k%. At the current price of $0.02, shares in Human Pheromone Sciences Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Human Pheromone Sciences Inc PE Ratio?

The Human Pheromone Sciences Inc PE ratio based on its reported earnings over the past 12 months is 1.97. The shares are currently trading at $0.02.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Human Pheromone Sciences Inc?

Human Pheromone Sciences Inc's management team is headed by:

William Horgan - CHM
Gregory Fredrick - CFO
Bernard Grosser - IND
Helen Leong - IND
Carson Tang - IND
Who are the major shareholders of Human Pheromone Sciences Inc?

Here are the top five shareholders of Human Pheromone Sciences Inc based on the size of their shareholding:

Similar to EROX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.